Inflammatory Bowel Disease and Streptococcus bovis

Teitelbaum, Jonathan E.; Triantafyllopoulou, Maria

doi:10.1007/s10620-005-9053-5

Cited by 19 publications

(10 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It can also be detected in human fecal samples. Its presence in humans is usually related to serious diseases such as colon carcinoma/ adenoma, inflammatory bowel disease (IBD), endocarditis, or bacteremia (Potter et al 1998;Dubrow et al 1991;Nielsen et al 2007;Sharara et al 2013;Teitelbaum and Triantafyllopoulou 2006).…”

Section: Cancermentioning

confidence: 99%

Microbiota’s role in health and diseases

El-Sayed

Aleya

Kamel

2021

Environ Sci Pollut Res

View full text Add to dashboard Cite

The microbiome is a term that usually refers to the community of various microorganisms that inhabit/live inside human/animal bodies or on their skin. It forms a complex ecosystem that includes trillions of commensals, symbiotics, and even pathogenic microorganisms. The external environment, diet, and lifestyle are the major determinants influencing the microbiome's composition and vitality. Recent studies have indicated the tremendous influence of the microbiome on health and disease. Their number, constitution, variation, and viability are dynamic. All these elements are responsible for the induction, development, and treatment of many health disorders. Serious diseases such as cancer, metabolic disorders, cardiovascular diseases, and even psychological disorders such as schizophrenia are influenced directly or indirectly by microbiota. In addition, in the last few weeks, accumulating data about the link between COVID-19 and the microbiota were published. In the present work, the role of the microbiome in health and disease is discussed. A deep understanding of the exact role of microbiota in disease induction enables the prevention of diseases and the development of new therapeutic concepts for most diseases through the correction of diet and lifestyle. The present review brings together evidence from the most recent works and discusses suggested nutraceutical approaches for the management of COVID-19 pandemic.

show abstract

Section: Cancermentioning

confidence: 99%

Microbiota’s role in health and diseases

El-Sayed

Aleya

Kamel

2021

Environ Sci Pollut Res

View full text Add to dashboard Cite

show abstract

“…49–56 While 3 small studies including 13–46 controls and corresponding 11 colorectal cancer, 47 pediatric inflammatory bowel disease (IBD) and 56 polyp patients failed to show any association, 52–54 five other studies found that SB carriage (either in stool or antibodies) rates were significantly higher in cancer patients than in controls. Interestingly, 3 studies also showed that patients with premalignant lesions (IBD or polyps) had intermediate SB carriage rate between cancer cases and controls.…”

Section: Epidemiological Studies Of Microbiome and Colorectal Cancermentioning

confidence: 99%

Gut microbiota, inflammation and colorectal cancer

2016

View full text Add to dashboard Cite

Although genes contribute to colorectal cancer, the gut microbiota are an important player. Accumulating evidence suggests that chronic infection and the ensuing inflammation contributes to tumor initiation and tumor progression. A variety of bacterial species and tumor-promoting virulence mechanisms have been investigated. Significant advances have been made in understanding the composition and functional capabilities of the gut microbiota and its roles in cancer. In the current review, we discuss the novel roles of microbiota in the progression of colon cancer. Although microbiota technically include organisms other than bacteria e.g., viruses and fungi, this review will primarily focus on bacteria. We summarize epidemiological studies of human microbiome and colon cancer. We discuss the progress in the scientific understanding of the interplay between the gut microbiota, barrier function, and host responses in experimental models. Further, we discuss the potential application in prevention, diagnosis, and therapy of colon cancer by targeting microbiota. We discuss the challenges lie ahead and the future direction in studying gut microbiome in colon cancer to close the gap between the basic sciences and clinical application.

show abstract

“…A marked resurgence of interest in the gastrointestinal commensal flora and local host-microbe interactions was observed since it was recognized that intestinal bacteria could be implicated in the pathogenesis of several inflammatory diseases like Crohn's disease or ulcerative colitis [17]. Both diseases are commonly suspected to result from altered host responses to intestinal bacterial flora [18], and are associated with cancer risk [17,19-21].…”

Section: Bacterial Pathogens and Cancermentioning

confidence: 99%

“…Both diseases are commonly suspected to result from altered host responses to intestinal bacterial flora [18], and are associated with cancer risk [17,19-21]. Accordingly, World Health Organization considered bacteria as possible causative agents for cancer development.…”

Section: Bacterial Pathogens and Cancermentioning

confidence: 99%

The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role

Abdulamir

Hafidh

Bakar

2011

J Exp Clin Cancer Res

276

209

View full text Add to dashboard Cite

Streptococcus bovis (S. bovis) bacteria are associated with colorectal cancer and adenoma. S. bovis is currently named S. gallolyticus. 25 to 80% of patients with S. bovis/gallolyticus bacteremia have concomitant colorectal tumors. Colonic neoplasia may arise years after the presentation of bacteremia or infectious endocarditis of S. bovis/gallolyticus. The presence of S. bovis/gallolyticus bacteremia and/or endocarditis is also related to the presence of villous or tubular-villous adenomas in the large intestine. In addition, serological relationship of S. gallolyticus with colorectal tumors and direct colonization of S. gallolyticus in tissues of colorectal tumors were found. However, this association is still under controversy and has long been underestimated. Moreover, the etiological versus non-etiological nature of this associationis not settled yet. Therefore, by covering the most of up to date studies, this review attempts to clarify the nature and the core of S. bovis/gallolyicus association with colorectal tumors and analyze the possible underlying mechanisms.

show abstract

Inflammatory Bowel Disease and Streptococcus bovis

Cited by 19 publications

References 26 publications

Microbiota’s role in health and diseases

Microbiota’s role in health and diseases

Gut microbiota, inflammation and colorectal cancer

The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role

Contact Info

Product

Resources

About